Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Juvena Therapeutics is a platform-driven, clinical-stage company unlocking the therapeutic potential of stem- cell secreted proteins and translating them into a growing pipeline of engineered biologics for chronic muscle and metabolic diseases. Juvena is achieving this through its fully integrated, end-to-end Artificial Intelligence (AI)-enabled drug discovery and development platform, JuvNET, that combines a compounding database mapping secreted proteins to specific disease phenotypes, in silico and in vit ...